Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: A cohort study.

Nevertheless, it must be pointed out that those five patients with active infection represent the 12.2% of anti-HCV-positive subjects, and the three patients unaware of their active infection were the 60% of the total active cases, highlighting that the efforts of case-findings cannot be reduced. Keywords: case-finding; epidemiology; HCV infection; SARS-CoV2 pandemic EN case-finding epidemiology HCV infection SARS-CoV2 pandemic 171 173 3 01/21/22 20220201 NES 220201 SHORT COMMUNICATION In Italy, since the first months of 2020, the COVID-19 pandemic has led the government to set a series of strict rules limiting all the non-essential clinical activities.1 These measures reduced the resources for managing potentially curable diseases such as HCV infection. The only significant difference between anti-HCV-positive and anti-HCV-negative subjects was an older age in HCV-positive. [Extracted from the article]